download-5

Digital Twins market Trends, Analysis by 2035

Roots Analysis has done a detailed study on “Digital Twins Market, 2022-2035”, covering key aspects of the market’s evolution and identifying potential future growth opportunities.

Key Market Insights

  • Presently, over 35digital twin products / services are available in the healthcare market which are being offered by players located across the globe
  • The partnership activity for digital twins in healthcare domain has grown at a CAGR of over 15%, in the past three years, 2019-2022
  • In order to tap into the lucrative opportunity associated with digital twins, various investment firms have invested over USD 6 billion in this market space, during the period 2018-2022
  • The projected future opportunity for companies engaged in this field is expected to be well distributed across different types of digital twins, therapeutic areas, areas of applications and key geographical regions
  • The latest report also provides key insights for Digital Twins Technology and Digital Twins Providers

Table of Contents

1.         PREFACE

1.1.      Scope of the Report

1.2.      Market Segmentation

1.3.      Research Methodology

1.4.      Key Questions Answered

1.5.      Chapter Outlines

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

3.1       Chapter Overview

3.2.      Overview of Digital Twins in Healthcare

3.3.1.   Types of Digital Twins Used in Healthcare

3.3.1.   Process Twin

3.3.2.   System Twin

3.3.3.   Human Body Twin

3.4.      Primary Applications of Digital Twins in the Healthcare Domain

3.4.1.   Asset / Process Management

3.4.2.   Evaluation of Clinical Trials

3.4.3.   Personalized Treatment

3.4.4.   Surgical Planning

3.5.      Concluding Remarks

4.         MARKET LANDSCAPE

4.1.      Chapter Overview

4.2.      Digital Twins in Healthcare: Overall Market Landscape

4.2.1.   Analysis by Status of Development

4.2.2.   Analysis by Therapeutic Area

4.2.3.   Analysis by Area(s) of Application

4.2.4.   Analysis by Type of Technology Used

4.2.5.   Analysis by End User

4.2.6.   Analysis by Type of Digital Twin

4.3.      Digital Twins in Healthcare: Developers Landscape

4.3.1.   Analysis by Year of Establishment

4.3.2.   Analysis by Company Size

4.3.3.   Analysis by Location of Headquarters

5.         KEY INSIGHTS

5.1.      Chapter Overview

5.2.      Analysis by Area of Application and Status of Development (Stacked Bar Chart)

5.3.      Analysis by Type of Technology Used and Type of Digital Twin (Heat Map

            Representation)

5.4.      Analysis by Type of End User and Type of Digital Twin (Grid Representation)

5.5.      Analysis by Area of Application and Location of Headquarters (Bar Chart)

5.6.      Analysis by Company Size and Location of Headquarters (Hybrid Chart)

6.         COMPANY COMPETITIVENESS ANALYSIS

6.1.      Chapter Overview

6.2.      Assumptions and Key Parameters

6.3.      Methodology

6.4.      Digital Twins in Healthcare: Company Competitiveness Analysis

6.4.1.   Company Competitiveness Analysis: Benchmarking of Portfolio Strength

6.4.2.   Company Competitiveness Analysis: Benchmarking of Partnership Activity

6.4.3.   Company Competitiveness Analysis: Benchmarking of Funding Activity

6.4.4.   Company Competitiveness Analysis: Very Small Companies

6.4.5.   Company Competitiveness Analysis: Small Companies

6.4.6.   Company Competitiveness Analysis: Mid-sized Companies

6.4.7.   Company Competitiveness Analysis: Large Companies

6.4.8.   Company Competitiveness Analysis: Very Large Companies

7.         COMPANY PROFILES

7.1.      Chapter Overview

7.2.      Babylon

7.2.1.   Company Overview

7.2.2.   Recent Developments and Future Outlook

7.3.      ExactCure

7.3.1.   Company Overview

7.3.2.   Recent Developments and Future Outlook

7.4.      ImmersiveTouch

7.4.1.   Company Overview

7.4.2.   Recent Developments and Future Outlook

7.5.      Navv Systems

7.5.1.   Company Overview

7.5.2.   Recent Developments and Future Outlook

7.6.      ThoughtWire

7.6.1.   Company Overview

7.6.2.   Recent Developments and Future Outlook

7.7.      Unlearn.AI

7.7.1.   Company Overview

7.7.2.   Recent Developments and Future Outlook

8.         PARTNERSHIPS AND COLLABORATIONS

8.1.      Chapter Overview

8.2.      Digital Twins in Healthcare: Partnerships and Collaborations

8.2.1.   Partnership Models

8.2.2.   List of Partnerships and Collaborations

8.2.3.   Analysis by Number of Partnership Instances

8.2.4.   Analysis by Type of Partnership

8.2.5.   Analysis by Year and Type of Partnership

8.2.6.   Analysis by Type of Partnership and Company Size

8.2.7.   Most Active Players: Analysis by Number of Partnerships

8.3.8.   Analysis by Region

8.3.9.   Intercontinental and Intracontinental Agreements

9.         FUNDING AND INVESTMENTS ANALYSIS

9.1.      Chapter Overview

9.2.      Types of Funding

9.3.      Digital Twins in Healthcare: List of Funding and Investments

9.3.1.   Analysis by Number of Funding Instances

9.3.2.   Analysis by Amount Invested

9.3.3.   Analysis by Type of Funding

9.3.4.   Analysis by Geography

9.3.5.   Most Active Players: Analysis by Number of Funding Instances

9.3.6.   Most Active Players: Analysis by Amount of Funding

9.3.7.   Most Active Investors: Analysis by Number of Funding Instances

9.4.      Concluding Remarks

10.       BERKUS START-UP VALUATION ANALYSIS

10.1.    Chapter Overview

10.2.    Key Assumptions and Methodology

10.3.    Berkus Start-Up Valuation: Total Valuation of Players

10.4.    Digital Twins in Healthcare: Benchmarking of Berkus Start-Up Valuation Parameters

10.4.1. AnatoScope: Benchmarking of Berkus Start-Up Valuation Parameters

10.4.2. ExactCure: Benchmarking of Berkus Start-Up Valuation Parameters

10.4.3. Klinik Sankt Moritz: Benchmarking of Berkus Start-Up Valuation

            Parameters

10.4.4. KYDEA: Benchmarking of Berkus Start-Up Valuation Parameters

10.4.5. TwInsight: Benchmarking of Berkus Start-Up Valuation Parameters

10.4.6. Yokogawa Insilico Biotechnology: Benchmarking of Berkus Start-Up Valuation Parameters

10.5.    Digital Twins in Healthcare: Benchmarking of Players

10.5.1. Sound Idea: Benchmarking of Players

10.5.2. Prototype: Benchmarking of Players

10.5.3. Management Experience: Benchmarking of Players

10.5.4. Strategic Relationships: Benchmarking of Players

10.5.5. Total Valuation: Benchmarking of Players

11.       MARKET FORECAST

11.1.    Chapter Overview

11.2.    Key Assumptions and Methodology

11.3.    Global Digital Twins Market in Healthcare Domain, 2022-2035

11.3.1.             Global Digital Twins Market in Healthcare Domain: Analysis by Type of Therapeutic Area

11.3.1.1. Global Digital Twins Market for Cardiovascular Disorders, 2022-2035

11.3.1.2. Global Digital Twins Market for Metabolic Disorders, 2022-2035

11.3.1.3. Global Digital Twins Market for Orthopedic Disorders, 2022-2035

11.3.1.4. Global Digital Twins Market for Other Disorders, 2022-2035

11.3.2.             Global Digital Twins Market in Healthcare Domain: Analysis by Type of Digital Twins

11.3.2.1. Global Process Twins Market in Healthcare Domain, 2022-2035

11.3.2.2. Global System Twins Market in Healthcare Domain, 2022-2035

11.3.2.3. Global Whole Body Twins Market in Healthcare Domain, 2022-2035

11.3.2.4. Global Body Part Twins Market in Healthcare Domain, 2022-2035

11.3.3.             Global Digital Twins Market in Healthcare Domain: Analysis by Type of Application

11.3.3.1. Global Digital Twins Market for Asset / Process Management, 2022-2035

11.3.3.2. Global Digital Twins Market for Personalized Treatment, 2022-2035

11.3.3.3. Global Digital Twins Market for Surgical Planning, 2022-2035

11.3.3.4. Global Digital Twins Market for Diagnosis, 2022-2035

11.3.3.5. Global Digital Twins Market for Other Applications, 2022-2035

11.3.4.             Global Digital Twins Market in Healthcare Domain: Analysis by End Users

11.3.4.1. Global Digital Twins Market for Pharmaceutical Companies, 2022-2035

11.3.4.2. Global Digital Twins Market for Medical Device Manufacturers, 2022-2035

11.3.4.3. Global Digital Twins Market for Healthcare Providers, 2022-2035

11.3.4.4. Global Digital Twins Market for Patients, 2022-2035

11.3.4.5. Global Digital Twins Market for Other End Users, 2022-2035

11.3.5.             Global Digital Twins Market in Healthcare Domain: Analysis by Geography

11.3.5.1. Digital Twins Market in in Healthcare Domain in North America, 2022-2035

11.3.5.2. Digital Twins Market in Healthcare Domain in Europe, 2022-2035

11.3.5.3. Digital Twins Market in Healthcare Domain in Asia, 2022-2035

11.3.5.4. Digital Twins Market in Healthcare Domain in Latin America, 2022-2035

11.3.5.5. Digital Twins Market in Healthcare Domain in Middle East and North Africa, 2022-2035

11.3.5.6. Digital Twins Market in Healthcare Domain in Rest of the World, 2022-2035

12.       CONCLUSION

13.       EXECUTIVE INSIGHTS

13.1.    Chapter Overview

13.2.    Dassault Systèmes

13.2.1. Company Snapshot

13.2.2. Interview Transcript: Barbara Holtz, Business Consultant

13.3.    TwInsight

13.3.1. Company Snapshot

13.3.2. Interview Transcript: Marek Bucki, Co-Founder and Chief Scientific Officer

13.4.    Unlearn.AI

13.4.1. Company Snapshot

13.4.2. Interview Transcript: Andrew Stelzer, Business Development Executive

13.5.    Yokogawa Insilico Biotechnology

13.5.1. Company Snapshot

13.5.2. Interview Transcript: Klaus Mauch, Managing Director and Chief Executive Officer

14.       APPENDIX I: TABULATED DATA

15.       APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

Get more details on the Digital Twins Market report https://www.rootsanalysis.com/reports/digital-twins-market.html

You may also be interested in the following titles:

Non-Viral / Intracellular Drug Delivery Systems Market
Dental 3D Printing Market 

You may also like to learn what our experts are sharing in Roots educational series:

Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

[email protected]